Medical Bulletin 29/April/2026 - Video

Here are the top medical news for today:

Scientists Identify Possible Brain Mechanism That May Act as Switch for Chronic Pain

Chronic pain may not just linger—it may be actively switched on by the brain.

A new study published in the Journal of Neuroscience has identified a hidden brain circuit that appears to decide whether short-term pain fades away or turns into long-lasting suffering. Researchers from the University of Colorado Boulder found that a small region deep in the brain, called the caudal granular insular cortex (CGIC), plays a central role in sustaining chronic pain.

Unlike acute pain—which acts as a protective signal after injury—chronic pain persists long after healing, often becoming a debilitating condition. This study suggests that the CGIC functions as a kind of “decision-maker,” determining whether pain signals should continue.

Using advanced techniques such as chemogenetics, researchers were able to selectively activate or inactivate specific neurons in animal models. They discovered that the CGIC is not essential for immediate pain perception but is crucial for maintaining pain over time. When this circuit was activated, it amplified signals from the somatosensory cortex to the spinal cord, effectively instructing the body to keep feeling pain—even in response to harmless touch, a phenomenon known as allodynia.

Strikingly, when scientists silenced this pathway shortly after injury, chronic pain never developed. Even more promising, turning off the circuit in animals already experiencing chronic pain caused the pain to disappear.

Such insights could pave the way for targeted therapies that go beyond traditional painkillers, including opioids, which carry risks of addiction and side effects.

While more research is needed before applying these findings to humans, the study opens the door to innovative treatments—ranging from targeted brain infusions to brain-machine interfaces—that could one day offer lasting relief for millions living with chronic pain.

REFERENCE: Jayson B. Ball, Maggie R. Finch, Jeremy A. Taylor, Zachariah Z. Smith, Igor Rafael Correia Rocha, Suzanne M. Green-Fulgham, Ethan B. Rowe, Joseph M. Dragavon, Connor J. McNulty, Renee A. Dreher, Imaad I. Siddique, Gavin Davis, Andrew M. Tan, Michael V. Baratta, Daniel S. Barth, Linda R. Watkins. Caudal Granular Insular Cortex to Somatosensory Cortex I: A Critical Pathway for the Transition of Acute to Chronic Pain. The Journal of Neuroscience, 2026; 46 (5): e1306252025 DOI: 10.1523/JNEUROSCI.1306-25.2025

New Study Examines Potential Brain Risks Associated With Fish Oil Intake

What if a supplement many consider “brain-friendly” could backfire under certain conditions? New research from the Medical University of South Carolina suggests that fish oil—widely consumed for its omega-3 benefits—may actually hinder brain recovery after repeated mild injuries.

Published in Cell Reports, the study explored how omega-3 fatty acids influence the brain’s ability to repair itself, particularly after traumatic events. While compounds like docosahexaenoic acid (DHA) are known to support brain structure and function, the researchers identified a potential issue with another major component of fish oil: eicosapentaenoic acid (EPA).

Using experimental models, the team found that elevated levels of EPA were linked to impaired repair of blood vessels in the brain. This is significant because recovery from brain injury relies heavily on restoring vascular integrity. When this process is disrupted, it can lead to longer-term complications, including cognitive decline.

The findings also highlighted a concept known as “context-dependent vulnerability.” In simple terms, fish oil may not have uniform effects across all situations. In the case of repeated mild traumatic brain injury—similar to what athletes or accident victims may experience—EPA appeared to interfere with the brain’s natural healing mechanisms. Mice exposed to long-term fish oil supplementation showed poorer neurological performance and signs of vascular instability over time.

Further laboratory studies on human brain cells supported these observations. EPA, unlike DHA, reduced the ability of endothelial cells to repair and form stable networks, a key step in healing damaged brain tissue.

Importantly, the researchers caution against generalizing these findings. Fish oil is not universally harmful, but its effects may vary depending on individual biology, injury status, and overall health.

As scientists continue to unravel how nutrients interact with complex systems like the brain, one message is clear: even widely trusted supplements deserve a closer, more personalized look.

REFERENCE: Eda Karakaya, Burak Berber, Onur Eskiocak, Jazlyn Edwards, Randy Bent Barker, Sarah Jamil, Weiguo Li, Yasir Abdul, Maria Ericsson, Thor Stein, Ann McKee, Adviye Ergul, Semir Beyaz, Onder Albayram. Eicosapentaenoic acid reprograms cerebrovascular metabolism and impairs repair after brain injury, with relevance to chronic traumatic encephalopathy. Cell Reports, 2026; 117135 DOI: 10.1016/j.celrep.2026.117135

Obesity May Cause Long-Term Molecular Changes in the Immune System: Study

Losing weight may change the scale—but not the body’s memory of obesity. A decade-long study published in EMBO Reports reveals that the immune system can retain a lasting “imprint” of obesity, potentially keeping disease risks elevated years after weight loss.

Led by University of Birmingham researchers, the study found that helper T cells—key players in immune defense—carry molecular “tags” formed during obesity. These tags arise through DNA methylation, an epigenetic process that alters how genes behave without changing the genetic code itself. Remarkably, this immune memory can persist for 5–10 years, even after a person achieves a healthy weight.

This lingering imprint may disrupt essential immune functions, including autophagy—the body’s way of clearing cellular waste—and immune aging. As a result, individuals who lose weight may still face a higher risk of conditions such as type 2 diabetes, cancer, and chronic inflammation long after their weight normalizes.

To build a comprehensive picture, researchers analyzed immune cells from diverse groups, including individuals undergoing weight-loss treatments, patients with Alström syndrome, and participants in exercise programs.

The findings challenge the assumption that weight loss alone immediately resets health risks. Instead, they suggest that long-term weight maintenance is crucial, as the immune system’s “memory” gradually fades over time. Encouragingly, scientists believe this process may be accelerated through targeted therapies.

Ultimately, the research reframes obesity as more than a temporary condition—it leaves a biological footprint that lingers beneath the surface.

REFERENCE: Niven, J., et al. (2026) DNA methylation-mediated memory of obesity in CD4 T lymphocytes perpetuates immune dysregulation. EMBO Reports. DOI: 10.1038/s44319-026-00765-w. https://link.springer.com/article/10.1038/s44319-026-00765-w